Pangaea Oncology — IPO · €3.8M

Pangaea closed a €3.8M capital increase for its listing on Spain's alternative market (MAB), at €2.70 per share, valuing it at €28.6M. It started trading on 29 December 2016. Impulsa Capital was registered adviser and Bankinter Securities liquidity provider; the Domínguez de Gor family (Mayoral, 5.5%) and Bankinter (2.17%) bought in at the listing.

Lead unknown RoundIPO Announced23 Dec 2016Not counted in totals CityBarcelona SectorHealthtech / Precision oncologySource V

Something wrong? Suggest a correction →